SERPINE1 Gene

title: SERPINE1 Gene

SERPINE1 Gene

Overview

title: SERPINE1 Gene

SERPINE1 Gene

Overview

SERPINE1 encodes plasminogen activator inhibitor-1 (PAI-1), the primary physiological inhibitor of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). As a member of the serpin superfamily, PAI-1 plays crucial roles in fibrinolysis regulation, extracellular matrix remodeling, and cellular signaling. Beyond its well-established functions in hemostasis and cardiovascular disease, PAI-1 has emerged as a significant contributor to neurodegenerative processes in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and vascular cognitive impairment. The protein's roles in neuroinflammation, synaptic plasticity, blood-brain barrier (BBB) integrity, and protein aggregation position it as both a biomarker and therapeutic target in neurodegeneration. [@teesalu2013]

Gene Information

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | SERPINE1 |
| Gene Name | Serpin Family E Member 1 (PAI-1) |
| Chromosomal Location | 7q22.1 |
| NCBI Gene ID | [5054](https://www.ncbi.nlm.nih.gov/gene/5054) |
| OMIM | [173360](https://www.omim.org/entry/173360) |
| UniProt | [P05121](https://www.uniprot.org/uniprot/P05121) |
| Ensembl | [ENSG00000105341](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105341) |
| RefSeq mRNA | NM_000321 |
| Protein Length | 402 amino acids |

</div>

Protein Structure and Function

Plasminogen activator inhibitor-1 is a 46 kDa glycoprotein that exists in three conformational states: active, latent, and cleaved. The active form rapidly forms covalent complexes with tPA and uPA, while the latent form represents an inactive conformation that can be converted to active by various stimuli. [@teesalu2013]

Canonical Functions

Brain-Specific Functions

Within the central nervous system, PAI-1 demonstrates additional functions:

• Synaptic Plasticity: PAI-1 modulates NMDA receptor signaling and affects long-term potentiation (LTP), with implications for memory formation. [@brown2021]
• Neuroinflammation: Astrocyte and microglial PAI-1 production influences cytokine expression and immune cell trafficking
• BBB Integrity: PAI-1 regulates pericyte function and endothelial-pericyte communication at the BBB. [@chen2022]
• Neural Stem Cell Biology: The protein affects neurogenesis and neural progenitor cell migration

Expression in the Brain

SERPINE1 is expressed in neurons, astrocytes, microglia, and endothelial cells within the brain. Basal expression is low but increases dramatically in response to inflammatory cytokines, oxidative stress, and aging. Cerebrospinal fluid PAI-1 levels are approximately 1/50th of plasma, though this ratio changes with neuroinflammation. The protein can cross the BBB in both directions under inflammatory conditions, establishing a connection between peripheral and CNS PAI-1 dynamics.

Disease Associations

Alzheimer's Disease

PAI-1 demonstrates multiple relationships with AD pathogenesis:

• Amyloid Metabolism: PAI-1 regulates tPA-mediated plasmin generation, which degrades amyloid-beta (Aβ) peptides. Elevated PAI-1 in AD brains reduces fibrinolysis and Aβ clearance. [@faut2022]
• Tau Pathology: PAI-1 expression correlates with hyperphosphorylated tau levels. The protein promotes tau aggregation and propagation through effects on extracellular proteolysis. [@schwab2020]
• Neuroinflammation: PAI-1 amplifies microglial activation and cytokine release. This creates a feed-forward loop where inflammation increases PAI-1, which further promotes inflammation.
• Vascular Contributions: Given the vascular components of AD pathology, PAI-1's role in fibrin deposition and small vessel disease is highly relevant.
• Genetic Associations: SERPINE1 polymorphisms influence AD risk and age of onset in multiple cohort studies. The 4G/5G promoter polymorphism shows variable associations.

Parkinson's Disease

In PD, PAI-1 exhibits complex relationships with alpha-synuclein pathology:

• Alpha-Synuclein Aggregation: PAI-1 interacts with alpha-synuclein and influences its aggregation kinetics. The protein may promote oligomer formation while inhibiting fibrilization.
• Dopaminergic Neuron Vulnerability: PAI-1 is elevated in the substantia nigra of PD patients, where it may contribute to dopaminergic neuron death through effects on neuroinflammation and blood-brain barrier function. [@tang2019]
• Microglial Activation: The protein promotes microglial activation and migration, potentially exacerbating neuroinflammation in PD.
• Oxidative Stress: PAI-1 expression is induced by oxidative stress, creating a pathogenic cycle in PD pathogenesis.
• Clinical Correlations: CSF PAI-1 levels correlate with disease severity and motor symptom progression in PD patients.

Amyotrophic Lateral Sclerosis

SERPINE1 plays significant roles in ALS pathophysiology:

• Motor Neuron Vulnerability: PAI-1 is elevated in ALS spinal cord and CSF, correlating with disease progression. The protein promotes neuroinflammation and microglial activation. [@hansen2021]
• Extracellular Matrix: ALS involves significant extracellular matrix remodeling, in which PAI-1 plays a key role through effects on plasmin generation and MMP activity.
• Vascular Components: Given the vascular contributions to ALS pathogenesis, PAI-1's role in blood-spinal cord barrier dysfunction is relevant.
• Genetic Modifiers: SERPINE1 polymorphisms influence ALS survival and age of onset in large GWAS studies.

Vascular Cognitive Impairment

PAI-1 is particularly relevant to vascular contributions to cognitive decline:

• Small Vessel Disease: PAI-1 promotes fibrin deposition in cerebral small vessels, contributing to vascular cognitive impairment. [@liu2020]
• White Matter Damage: The protein affects white matter integrity through effects on perfusion and blood-brain barrier function.
• Post-Stroke Recovery: Elevated PAI-1 impairs functional recovery after stroke through effects on plasticity and inflammation.

Other Neurodegenerative Conditions

• Frontotemporal Dementia: PAI-1 elevations in specific subtypes, particularly those with prominent neuroinflammation
• Huntington's Disease: Elevated PAI-1 in striatum, correlating with disease progression
• Multiple Sclerosis: PAI-1 in demyelinating lesions; affects remyelination efficiency

Mechanism of Action in Neurodegeneration

Neuroinflammation Amplification

PAI-1 promotes neuroinflammation through multiple mechanisms:

Blood-Brain Barrier Dysfunction

PAI-1 contributes to BBB breakdown:

• Pericyte Function: PAI-1 affects pericyte survival and contractility
• Endothelial Junction Integrity: The protein influences tight junction protein expression
• Matrix Deposition: PAI-1 promotes basement membrane accumulation

Synaptic Dysfunction

PAI-1 affects synaptic plasticity:

• NMDA Receptor Modulation: PAI-1 influences NMDA receptor trafficking and signaling
• LTP Impairment: Elevated PAI-1 correlates with impaired long-term potentiation
• Dendritic Spine Changes: The protein affects spine density and morphology

Protein Aggregation

PAI-1 interacts with aggregation-prone proteins:

• Amyloid-Beta: Modulates aggregation kinetics and toxicity
• Tau: Promotes hyperphosphorylation and aggregation
• Alpha-Synuclein: Influences oligomer formation

Genetic Variants

| Variant | Location | Effect | Clinical Relevance |
|---------|----------|--------|-------------------|
| 4G/5G | Promoter (-675) | Altered expression | Cardiovascular disease, possibly AD |
| 1100T>C (Vallle) | Exon 9 | Altered activity | Thrombosis risk |
| 3103G>A | 3'UTR | mRNA stability | May affect expression |

The 4G/5G promoter polymorphism has been extensively studied in neurodegeneration, with inconsistent results across populations and diseases.

Therapeutic Implications

PAI-1 Inhibitors

Several PAI-1 inhibitors are in development:

• Small Molecule Inhibitors: TM5441 and related compounds已进入临床前评估
• Natural Products: Various flavonoids and polyphenols show PAI-1 inhibitory activity
• Neutralizing Antibodies: Monoclonal antibodies against PAI-1 are under development

Repurposing Opportunities

Existing drugs with PAI-1 modulatory effects:

• Statins: Some statins reduce PAI-1 expression
• ACE Inhibitors: Show PAI-1 reducing effects
• Thiazolidinediones: PPARγ agonists decrease PAI-1 levels

Mechanism-Based Approaches

• tPA Enhancement: Agents that increase tPA activity can overcome PAI-1 inhibition
• Fibrinolytic Therapy: Recombinant tPA administration in appropriate contexts
• Gene Therapy: Viral vector-mediated PAI-1 knockdown approaches

Biomarker Potential

PAI-1 possesses significant biomarker utility:

• CSF PAI-1: Elevated in AD, PD, ALS; correlates with disease severity
• Blood PAI-1: Systemic inflammation marker; less CNS-specific
• Combined Biomarkers: PAI-1 with tPA ratio shows diagnostic promise

Research Directions

Key areas for future investigation:

• PAI-1 therapeutic targeting in human neurodegeneration trials
• Mechanism of PAI-1 effects on synaptic plasticity
• BBB penetration by PAI-1 modulators
• Genetic stratification based on SERPINE1 variants
• Combination therapy with existing treatments

References

See Also

• [Plasminogen Activator System](/mechanisms/plasminogen-activator-system)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Vascular Cognitive Impairment](/diseases/vascular-cognitive-impairment)
• [Neuroinflammation Mechanisms](/mechanisms/neuroinflammation-mechanisms)
• [Blood-Brain Barrier in Neurodegeneration](/mechanisms/blood-brain-barrier-neurodegeneration)
• [Synaptic Dysfunction Mechanisms](/mechanisms/synaptic-dysfunction-mechanisms)
• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/5054)
• [OMIM](https://www.omim.org/entry/173360)
• [UniProt](https://www.uniprot.org/uniprot/P05121)
• [Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105341)

Pathway Diagram

The following diagram shows the key molecular relationships involving SERPINE1 Gene discovered through SciDEX knowledge graph analysis: